This is the story of how one of the largest insurance companies in the world is transforming itself into a “health maintenance organisation” (HMO) to meet China’s rising social demand.
China's personal insurance sector is predicted to grow in the range of 5% to 10% by 2035, a potential expansion primarily ...
AstraZeneca's blockbuster breast cancer drug Enhertu will be added to China's state-run health insurance scheme from Jan. 1, ...